Japan Entry Acceleration Program 2025 (JEAP 2025)

About

The Japan Entry Acceleration Program 2025 (JEAP 2025) offers startups in the regenerative medicine and gene therapy sectors a unique opportunity to accelerate their entry into the Japanese market through comprehensive support, including market insights, expert guidance, and a Demo Day to showcase their innovations to potential partners and investors, all at no cost to participants.

Benefits

• Free participation
• Online workshops to understand the Japanese market and prepare for collaboration opportunities
• Online mentoring and business guidance
• Matching meetings with Japanese CDMO/CRO and pharmaceutical companies
• Demo Day to showcase project results to Japanese businesses, investors, and ecosystem partners

Eligibility Criteria

• Startups focused on regenerative medicine, cell therapy, gene therapy, and advanced therapy medicinal products (ATMPs)
• Companies with confirmed clinical development candidates
• Companies interested in entering the Japanese market
• Commitment to participate in multiple online meetings and events
• Ability to attend the Demo Day in Japan and assist with promotional activities

Target Region

Global

Target Sector

Regenerative Medicine and Gene Therapy